Yan Leyfman, MD, Hematology-Oncology Fellow at NewYork-Presbyterian Brooklyn Methodist Hospital and Executive Director of MedNews Week, shared on LinkedIn:
“MedNews Week Medical Spotlight with Dr. Karin Tawagi.
The treatment landscape for muscle-invasive bladder cancer (MIBC) is rapidly evolving—and we’re excited to welcome Dr. Karine Tawagi to MedNews Week for a timely discussion on what these advances mean for clinical practice.
Dr. Tawagi is an Assistant Professor of Clinical Medicine and Fellowship Program Director at the University of Illinois Chicago, combining expertise in genitourinary oncology with a deep commitment to educating the next generation of oncologists.
Evolving Treatment Paradigms in Muscle-Invasive Bladder Cancer
We’ll explore the changing therapeutic landscape, emerging treatment strategies, and how new evidence is reshaping the way we approach patients with MIBC.
Join us for another MedNews Week Medical Spotlight featuring the experts helping move oncology forward.
Don’t miss this exciting episode.”
You can also read: CAR-T Therapy in Aggressive B-Cell Lymphoma and the Future of Cellular Therapy – MedNews Week
